Alembic receives USFDA tentative approval for Brexpiprazole Tablets

Evonik opens new facility for pharmaceutical lipids in Germany

New GMP facility for clinical and small-scale commercial pharmaceutical lipids

Dr. Reddy's Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolio

The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.

Vaishali Pharma receives multiple orders worth US$ 73.85 million

This order is subject to initial advance payment as per the agreed terms of the contract

Strides flagship facility in Bangalore receives USFDA inspection closure

Briefs: Neuland Laboratories, Cipla and Zydus

Cipla has received 8 inspectional observations in Form 483

Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg

According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million

Sanofi announces change in R&D leadership

Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim

Krsnaa Diagnostics completes Tripura project

Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.

Innova Captab gets SEBI nod to raise funds via IPO

The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore